Experiment: 7UQT

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
2	2D 1H-13C HSQC	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
3	2D 1H-13C HSQC aromatic	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
4	2D 1H-1H TOCSY	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
5	2D 1H-1H COSY	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
6	2D 1H-1H NOESY	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
11	3D HBHA(CO)NH	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
10	3D HNCACB	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
9	3D HNCO	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
8	3D HCCH-TOCSY	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
7	3D HCCH-COSY	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
16	3D 1H-13C NOESY	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
15	3D 1H-13C NOESY aromatic	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
14	3D 1H-15N NOESY	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
13	2D HBCBCGCDHD	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800
12	2D HBCBCGCDCEHE	250 uM [U-13C; U-15N] 6H-QseM, 20 mM sodium chloride, 10 mM sodium phosphate	2 % v/v glycerol, 98 % v/v D2O	24 mM	7.5	1 atm	298	Bruker AVANCE III 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	800

NMR Refinement
Method	Details	Software
torsion angle dynamics	CYANA was provided with a list of 680 chemical shift assignments, 1177 distance and 124 torsion angle restraints. Initial structure calculations were performed using a family of 100 structures each running for 10,000 steps of torsion angle dynamics. The 20 lowest energy structures were used for subsequent water refinement via the RECOORD method (Nederveen et al., 2005) with 500 annealing runs. The lowest energy 100 structures after annealing were refined in water with the 20 lowest energy structures creating the final ensemble	CYANA

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (medoid)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CYANA		Guntert P. Mumenthaler C. Wuthrich K.
2	structure calculation	CYANA		Guntert P. Mumenthaler C. Wuthrich K.
3	chemical shift assignment	CcpNmr Analysis		Vranken W.F. Boucher W. Stevens T.J. Fogh R.H. Pajon A. Llinas M. Ulrich E.L. Markley J.L. Ionides J. Laue E.D.
4	peak picking	CcpNmr Analysis		Vranken W.F. Boucher W. Stevens T.J. Fogh R.H. Pajon A. Llinas M. Ulrich E.L. Markley J.L. Ionides J. Laue E.D.

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.